Charles River Laboratories
CRL
S$229.76
Share price
-0.30%
Change (1 day)
-28.03%
Change (1 year)
Categories
Charles River Laboratories (CRL) - Cash on Hand
Cash on Hand as of March 2025 : S$0.29 Billion
According to Charles River Laboratories
's latest financial reports the company has S$0.29 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Charles River Laboratories - Cash on Hand chart (from 2000 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$0.26 B | -27.63% |
| 2023-12-31 | S$0.36 B | 16.57% |
| 2022-12-31 | S$0.31 B | -3.84% |
| 2021-12-31 | S$0.32 B | 7.43% |
| 2020-12-31 | S$0.30 B | -5.78% |
| 2019-12-31 | S$0.32 B | 20.11% |
| 2018-12-31 | S$0.26 B | 4.29% |
| 2017-12-31 | S$0.25 B | 46.38% |
| 2016-12-31 | S$0.17 B | -10.29% |
| 2015-12-31 | S$0.19 B | -15.87% |
| 2014-12-31 | S$0.23 B | 9.97% |
| 2013-12-31 | S$0.21 B | 48.63% |
| 2012-12-31 | S$0.14 B | 48.09% |
| 2011-12-31 | S$96.17 M | -60.49% |
| 2010-12-31 | S$0.24 B | -27.14% |
| 2009-12-31 | S$0.33 B | -4.08% |
| 2008-12-31 | S$0.34 B | 0.7% |
| 2007-12-31 | S$0.34 B | 23.4% |
| 2006-12-31 | S$0.28 B | 44.53% |
| 2005-12-31 | S$0.19 B | -42.78% |
| 2004-12-31 | S$0.33 B | 2.07% |
| 2003-12-31 | S$0.33 B | 56.25% |
| 2002-12-31 | S$0.21 B | 97.06% |
| 2001-12-31 | S$0.10 B | 87.87% |
| 2000-12-31 | S$57.41 M | 129.75% |
| 1999-12-31 | S$24.99 M | -38.99% |
| 1998-12-31 | S$40.96 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | S$0.89 B | 203.99% | 🇺🇸 USA |
 SCYNEXIS SCYX | S$52.28 M | -82.30% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | S$7.65 B | 2,492.91% | 🇺🇸 USA |